Brookline Capital Markets analyst Kumaraguru Raja initiated coverage with a Buy rating on Vaxart (VXRT - Research Report) yesterday and set a price target of $7.00. The company's shares closed yesterday at $4.29.Raja covers the Healthcare sector, focusing on stocks such as Veru, Vaxart, and 9 Meters Biopharma. According to TipRanks, Raja has an average return of 0.5% and a 35.09% success rate on recommended stocks. The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Vaxart with a $6.50 average price target.See the top stocks recommended by analysts >>The company has a one-year high of $10.33 and a one-year low of $2.49.
https://www.tipranks.com/news/blurbs/vaxart-vxrt-receives-a-new-rating-from-brookline-capital-markets-2?utm_source=advfn.com&utm_medium=referral